Protective Effects of rLPG3 Plus Freund’s Incomplete Adjuvant on Parasitism, Hepatic Function, and Immune Modulation in Experimental Visceral Leishmaniasis
ACS Infectious Diseases · 13.02.2026 · 12 (2) · 794-804
DOI: 10.1021/acsinfecdis.5c01006 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 20.01.2026. Verfasst von Daniel Silva Sena Bastos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunoparasitology, Department of General Biology, Federal University of Viçosa, Viçosa, Minas Gerais, MG, 36570-000, Brazil. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Liver, Leishmania infantum, Freund's Adjuvant. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico.
Abstract (Originalsprache)
High Resolution Image Download MS PowerPoint Slide Visceral leishmaniasis (VL) is a neglected tropical disease affecting humans and dogs, particularly in urban settings. Current therapies are limited by toxicity, lengthy regimens, and emerging drug resistance. No human vaccine is available, and only a few licensed formulations exist for canine use. Here, we evaluated a recombinant Leishmania infantum lipophosphoglycan-3 (rLPG3) antigen formulated with Freund’s incomplete adjuvant (FIA) against Leishmania infantum challenge in BALB/c mice. The formulation reduced hepatic parasitism, increased antioxidant enzyme activities (superoxide dismutase, catalase, glutathione S-transferase), and raised total antioxidant capacity and hepatic nitrite/nitrate, while lipid and protein oxidation markers remained unchanged. Vaccination preserved liver architecture, lowered AST/ALT, reduced granuloma number and area, and shifted granuloma maturation toward organized lesions with greater macrophage content; PAS staining indicated higher hepatocyte glycogen in the rLPG3+FIA group. Serologically, rLPG3+FIA increased IgG1 and the IgG1/IgG2a ratio, indicating a Th2-skewed profile concomitant with reduced parasitism. Within the constraints of this model, time point, and the proof-of-concept use of FIA, these convergent readouts support rLPG3 as a promising antigen for further preclinical development─prioritizing licensable veterinary adjuvants to enable translation into canine VL vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunoparasitology, Department of General Biology, Federal University of Viçosa, Viçosa, Minas Gerais, MG, 36570-000, Brazil.
- Laboratory of Immunochemistry and Glycobiology, Department of General Biology, Federal University of Viçosa, Viçosa, Minas Gerais, MG, 36570-000, Brazil.
- Laboratory of Structural Biology, Department of General Biology, Federal University of Viçosa, Viçosa, Minas Gerais, MG, 36570-000, Brazil.
- Laboratory of Structural Biology, Department of Animal Biology, Federal Rural University of Rio de Janeiro, Seropédica, Rio de Janeiro, 23890-000, Brazil.
ORCID-Profile: Neverton José Silva Ferreira, Eduardo de Almeida Marques da Silva
Förderung
- Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
Zitieren
APA
Bastos, D. S. S., Miranda, B. M., Rooke, C. I., Ferreira, N. J. S., Ervilha, L. O. G., Carvalho, R. P. R., Souza, A. C. F., Neves, M. M., Oliveira, L. L., & Marques da Silva, E. A. (2026). Protective Effects of rLPG3 Plus Freund’s Incomplete Adjuvant on Parasitism, Hepatic Function, and Immune Modulation in Experimental Visceral Leishmaniasis. ACS Infectious Diseases, 12(2), 794-804. https://doi.org/10.1021/acsinfecdis.5c01006
Vancouver
Bastos DSS, Miranda BM, Rooke CI, Ferreira NJS, Ervilha LOG, Carvalho RPR, et al. Protective Effects of rLPG3 Plus Freund’s Incomplete Adjuvant on Parasitism, Hepatic Function, and Immune Modulation in Experimental Visceral Leishmaniasis. ACS Infectious Diseases. 2026;12(2):794-804. doi:10.1021/acsinfecdis.5c01006
BibTeX
@article{Bastos2026,
author = {Bastos, Daniel Silva Sena and Miranda, Bianca Meirelles and Rooke, Caroline Itagiba and Ferreira, Neverton José Silva and Ervilha, Luiz Otávio Guimarães and Carvalho, Renner Philipe Rodrigues and Souza, Ana Cláudia Ferreira and Neves, Mariana Machado and Oliveira, Leandro Licursi de and Marques da Silva, Eduardo de Almeida},
title = {Protective Effects of rLPG3 Plus Freund’s Incomplete Adjuvant on Parasitism, Hepatic Function, and Immune Modulation in Experimental Visceral Leishmaniasis},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {2},
pages = {794--804},
doi = {10.1021/acsinfecdis.5c01006}
}
EUVIMED